Search - tctmd.com

Displaying 841 - 860 of 4928

Sort: Relevancy | Date

Presentation TCT 2022

COSIRA-II – Trial Design and Status Update

Presenter: Gregg Stone

September 18, 2022

Presentation TCT 2022

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

Drug Elution: Challenges and Opportunities

Presenter: Sahil Parikh

September 18, 2022

Presentation TCT 2022

TCT 181: Effect of Lipoprotein(a) in Patients With Coronary Calcification Undergoing Percutaneous Coronary Intervention

Presenter: Deshan Yuan

September 18, 2022

Presentation TCT 2022

Coronary DCB in HBR Patients: An Alternative to DES?

Presenter: Tuomas Rissanen

September 18, 2022

Presentation TCT 2022

Role of Drug-Eluting Technologies as Definitive Therapy

Presenter: Beau Hawkins

September 18, 2022

Presentation TCT 2022

Reflow Medical’s Temporary Spur DES System

Presenter: Jihad Mustapha

September 17, 2022

Presentation TCT 2022

MOTIV BRS (REVA Vascular)

Presenter: Christopher Metzger

September 17, 2022

Presentation TCT 2022

APTITUDE PLLA BRS (R3 Vascular)

Presenter: Mahmood K. Razavi

September 17, 2022

Presentation TCT 2022

Hybrid Nano-Coating DES for BTK Disease

Presenter: Terumitsu Hasebe

September 17, 2022

Presentation TCT 2022

Conclusion

Presenter: Roxana Mehran

September 17, 2022

Presentation TCT 2022

World’s largest RCT for DM - ABILITY DIABETES GLOBAL: Implication and Importance

Presenter: Marie-Claude Morice

September 17, 2022

Presentation TCT 2022

Diabetes and DES+DCB platform: the perfect match

Presenter: Luca Testa

September 17, 2022

Presentation TCT 2022

The role of imaging in DM patients: case presentations from ABILITY RCT

Presenter: Antonio Mangieri

September 17, 2022

Presentation TCT 2022

The Innovative DES+DCB platform

Presenter: Fazila-Tun-Nesa Malik

September 17, 2022

Presentation TCT 2022

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

Presenter: KI-HYUN JEON

September 17, 2022

Presentation TCT 2022

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Presenter: Bruno Scheller

September 17, 2022

Presentation TCT 2022

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Presenter: Christian M. Spaulding

September 17, 2022

Presentation TCT 2022

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Presenter: Marta Konopko

September 17, 2022

Presentation TCT 2022

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Presenter: Ron Waksman

September 17, 2022

Advertisement

COSIRA-II – Trial Design and Status Update

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Drug Elution: Challenges and Opportunities

TCT 181: Effect of Lipoprotein(a) in Patients With Coronary Calcification Undergoing Percutaneous Coronary Intervention

Coronary DCB in HBR Patients: An Alternative to DES?

Role of Drug-Eluting Technologies as Definitive Therapy

Reflow Medical’s Temporary Spur DES System

MOTIV BRS (REVA Vascular)

APTITUDE PLLA BRS (R3 Vascular)

Hybrid Nano-Coating DES for BTK Disease

Conclusion

World’s largest RCT for DM - ABILITY DIABETES GLOBAL: Implication and Importance

Diabetes and DES+DCB platform: the perfect match

The role of imaging in DM patients: case presentations from ABILITY RCT

The Innovative DES+DCB platform

TCT 29: Platelet Reactivity and Clinical Outcomes After Drug-Eluting Stent Implantation in East Asian Patients with Diabetes: Results From the PTRG-DES Registry

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content